Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab

Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab

A 62-year-old male was diagnosed with chronic lymphocytic leukemia (CLL) and treated with a fludarabine-containing regimen which maintained the disease in a partial response. Nine years after diagnosis, a rapidly growing systemic lymphadenopathy was observed, and a biopsy specimen revealed the prese...

Full description

Bibliographic Details
Main Authors: Shinya Rai, Hirokazu Tanaka, Ko Fujimoto, Takahiro Kumode, Hiroaki Inoue, Yasuhiro Taniguchi, Yasuyoshi Morita, J. Luis Espinoza, Yoichi Tatsumi, Takashi Ashida, Ryota Matsuoka, Yukie Yara Kikuti, Naoya Nakamura, Itaru Matsumura
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Cancers
Subjects:
lymphoproliferative diseases
Hodgkin lymphoma
chronic lymphocytic leukemia
clonality
Hodgkin/Reed-Sternberg cell
bendamustine
Online Access:http://www.mdpi.com/2072-6694/10/9/304

Internet

http://www.mdpi.com/2072-6694/10/9/304

Similar Items